📰 Prostate News
Page 119 - Prostate News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Prostate. Real-time updates on events, politics, business and more.
January 24, 2022
Broccoli may contain advantages beyond nutrition. A molecule found in broccoli, cabbage and more digests down into DIM, a compound with brighter benefits than the name implies, such as inducing cell death in breast, prostate and colon cancer.
January 21, 2022
Results of a large study led by UCLA Jonsson Comprehensive Cancer Center researchers could help guide treatment planning for patients with high-risk prostate cancer.
January 20, 2022
Artificial intelligence (AI) systems can diagnose prostate cancer biopsies with the same level of accuracy as specialist uropathologists, and better than many general pathologists, a new research has found.
January 19, 2022
Many cases of early prostate cancer are dominated by cells that are slow-growing, often leading to a clinical decision to monitor for progression before initiating treatments that can have adverse side effects.
January 19, 2022
Prostate cancer is the leading cause of cancer in men worldwide, and radiotherapy is one of the common forms of treatment.
January 14, 2022
Researchers at Karolinska Institutet in Sweden have together with international collaborators completed a comprehensive international validation of artificial intelligence (AI) for diagnosing and grading prostate cancer.
January 14, 2022
Prostate cancer is the second deadliest cancer in men in the United States. The incidence of prostate cancer in Black men is nearly 60% greater than the incidence in white men.
January 13, 2022
LONDON (dpa-AFX) - AstraZeneca (AZN.L, AZN) announced Thursday new data in liver, biliary tract and prostate cancer treatment with practice-changing Imfinzi and Lynparza.The company noted that
January 10, 2022
A blood test, combined with a risk model based on an individual's history, more accurately determines who is likely to benefit from lung cancer screening than the current U.S. recommendation, according to a study published today in the Journal of Clinical Oncology led by researchers from The University of Texas MD Anderson Cancer Center.
January 9, 2022
The Society of Nuclear Medicine and Molecular Imaging and peer medical groups have issued appropriate use criteria (AUC) for prostate-specific membrane antigen (PSMA) PET imaging.